UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Assessing the need for psychooncological support: screening instruments in combination with patients' subjective evaluation may define psychooncological pathways

Psycho-oncology (Chichester, England), 2015-12, Vol.24 (12), p.1784-1791

2015

Link zum Volltext

Verfügbarkeit prüfen

Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma

BMC cancer, 2011-01, Vol.11 (1), p.42-42, Article 42

2011

Link zum Volltext

Verfügbarkeit prüfen

Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality

JNCI : Journal of the National Cancer Institute, 2016-06, Vol.108 (6), p.djv428-djv428

2016

Link zum Volltext

Verfügbarkeit prüfen

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer

Breast cancer research and treatment, 2020-08, Vol.183 (1), p.137-144

2020

Link zum Volltext

Verfügbarkeit prüfen

HER2-targeted therapy influences CTC status in metastatic breast cancer

Breast cancer research and treatment, 2020-07, Vol.182 (1), p.127-136

2020

Link zum Volltext

Verfügbarkeit prüfen

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression

Annals of oncology, 2014-08, Vol.25 (8), p.1551-1557

2014

Link zum Volltext

Verfügbarkeit prüfen

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial

Breast (Edinburgh), 2012-02, Vol.21 (1), p.27-33

2012

Link zum Volltext

Verfügbarkeit prüfen

Time trends of neoadjuvant chemotherapy for early breast cancer

International journal of cancer, 2020-12, Vol.147 (11), p.3049-3058

2020

Link zum Volltext

Verfügbarkeit prüfen

Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network

Archives of gynecology and obstetrics, 2017-05, Vol.295 (5), p.1239-1245

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer

Breast cancer research and treatment, 2016-11, Vol.160 (2), p.277-290

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial

Annals of oncology, 2016-06, Vol.27 (6), p.1035-1040

2016

Link zum Volltext

Verfügbarkeit prüfen

Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer

Journal of cancer research and clinical oncology, 2013-11, Vol.139 (11), p.1909-1916

2013

Link zum Volltext

Verfügbarkeit prüfen

CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary

Journal of cancer research and clinical oncology, 2013-04, Vol.139 (4), p.551-556

2013

Link zum Volltext

Verfügbarkeit prüfen

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

Annals of oncology, 2018-01, Vol.29 (1), p.178-185

2018

Link zum Volltext

Verfügbarkeit prüfen

Selective microdochectomy after ductoscopic wire marking in women with pathological nipple discharge

BMC cancer, 2009-05, Vol.9 (1), p.151-151, Article 151

2009

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients

Annals of oncology, 2007-03, Vol.18 (3), p.479-484

2007

Link zum Volltext

Verfügbarkeit prüfen

Risk factors and survival outcome in cerebral metastatic breast cancer

Medical oncology (Northwood, London, England), 2014-03, Vol.31 (3), p.862-862, Article 862

2014

Link zum Volltext

Verfügbarkeit prüfen

Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine

Annals of oncology, 2007-12, Vol.18 (12), p.1981-1984

2007

Link zum Volltext

Verfügbarkeit prüfen

Impaired Bone Microenvironment: Correlation between Bone Density and Presence of Disseminated Tumor Cells

Anticancer research, 2011-12, Vol.31 (12), p.4423-4428

2011

Link zum Volltext

Verfügbarkeit prüfen

Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma

Journal of cancer research and clinical oncology, 2017-11, Vol.143 (11), p.2183-2188

2017

Link zum Volltext

Verfügbarkeit prüfen

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial

European journal of cancer (1990), 2004-05, Vol.40 (7), p.988-997

2004

Link zum Volltext

Verfügbarkeit prüfen

Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer

European journal of gynaecological oncology, 2004, Vol.25 (3), p.339

2004

Link zum Volltext

Verfügbarkeit prüfen

Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate)

Anticancer research, 2002-07, Vol.22 (4), p.2325

2002

Link zum Volltext

Verfügbarkeit prüfen

Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers

Journal of cancer research and clinical oncology, 2006-04, Vol.132 (4), p.265-274

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

ThemaAdult

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(32)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(32)
Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Middle Aged
(31)
Female
(30)
Aged
(24)
Breast Cancer
(19)
Breast Neoplasms - Pathology
(19)
Tumors
(13)
Biological And Medical Sciences
(12)
Breast Neoplasms - Drug Therapy
(12)
Medical Sciences
(12)
Gynecology. Andrology. Obstetrics
(11)
Mammary Gland Diseases
(10)
Neoplasm Staging
(10)
Prognosis
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Pharmacology. Drug Treatments
(9)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessing the need for psychooncological support: screening instruments in combination with patients' subjective evaluation may define psychooncological pathways

Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma

Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer

HER2-targeted therapy influences CTC status in metastatic breast cancer

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial

Time trends of neoadjuvant chemotherapy for early breast cancer

Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network

Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer

Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial

Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer

CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

Selective microdochectomy after ductoscopic wire marking in women with pathological nipple discharge

Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients

Risk factors and survival outcome in cerebral metastatic breast cancer

Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine

Impaired Bone Microenvironment: Correlation between Bone Density and Presence of Disseminated Tumor Cells

Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial

Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer

Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate)

Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers

Aktive Filter

Suchergebnisse filtern